Analysts revise ratings and price targets for Affiliated Managers Group, Goldman Sachs and Vaxcyte
SPY•Analysts revised ratings and price targets for numerous U.S.-listed companies. Jefferies raised Affiliated Managers Group’s target to $456 from $441 and cut Goldman Sachs’ to $1,124 from $1,299, while Needham raised Vaxcyte’s target to $122 from $110.
1. Analyst target changes
The roundup lists analyst rating and price-target changes for a wide range of U.S.-listed companies. Among the highlighted moves, JP Morgan raised Regeneron Pharmaceuticals’ target to $950 from $900, and Jefferies raised Charles Schwab’s target to $131 from $126.
2. Other notable revisions
The roundup also includes two target increases for Advanced Micro Devices: Citigroup raised its target to $800 from $575, and Mizuho raised its target to $705 from $580. Wells Fargo raised Meta Platforms’ target to $1,000 from $796.
